Annotation Detail

Information
Associated Genes
KIT
Associated Variants
KIT EXPRESSION
KIT EXPRESSION
Associated Disease
endometrial cancer
Source Database
CIViC Evidence
Description
Case Report of a 42-year old patient with low-grade endometrial stromal sarcoma. IHC was focally positive for CD117. Imatinib mesylate led to complete metabolic response (PET-CT).
Variant Origin
N/A
Variant Origin
N/A
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1024
Gene URL
https://civic.genome.wustl.edu/links/genes/29
Variant URL
https://civic.genome.wustl.edu/links/variants/429
Rating
2
Evidence Type
Predictive
Disease
Endometrial Cancer
Evidence Direction
Supports
Drug
Imatinib
Evidence Level
C
Clinical Significance
Sensitivity/Response
Pubmed
18607592
Drugs
Drug NameSensitivitySupported
ImatinibSensitivitytrue